Abstract
Macrophage migration inhibitory factor (MIF) is a significant regulator of inflammatory diseases, and local inflammation plays an important role in the aseptic loosening of failed total hip arthroplasty (THA). A high-level MIF expression was found in the interfacial membrane around implants. However, the cause of increased MIF expression and the action of MIF in the process of aseptic-loosening implant is still unknown. This study is to investigate MIF expression and its upregulating effect on matrix metalloproteinases (MMPs) expression in the particles-stimulated air pouches in mice that appear to closely resemble the interfacial membranes. A total of 48 murine air pouches were divided into four groups, and were injected with PBS, titanium particles suspensions, titanium particles suspensions with neutralizing antibody of MIF, and titanium particles suspensions with normal IgG, respectively. Histological and cytokine responses were evaluated. The inflammatory reaction of air pouch membranes induced by titanium particles was significantly suppressed by neutralizing antibody. The levels of MIF protein and mRNA were significantly increased in the titanium particles-stimulated air pouch membranes compared with the control groups. So were the levels of MMP13 protein and mRNA. However, the levels of MMP13 protein and mRNA were significantly reduced by neutralizing antibody. Our study demonstrates that titanium particles can cause the air pouch membranes to increase the expression of MIF, which upregulates the production of MMP13 and induces inflammatory reaction in vivo. The results indicate that MIF may play an important role in the process of aseptic-loosening implants after THA.
Similar content being viewed by others
References
David JR (1966) Delayed hypersensitivity in vitro: its mediation by cell free substances forms by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 56(1):72–77
Bloom BR, Bennett B (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153(731):80–82
Calandra T, Bernhagen J, Mitchell RA, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179(6):1895–1902
Calandra T, Roger T (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3(10):791–800
Calandra T, Bernhagen J, Mets CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R (1995) MIF as a glucocorticoid induced modulator of cytokine production. Nature 377(6544):68–71
Harris WH (1995) The problem is osteolysis. Clin Orthop Relat Res 311:46–53
Clohisy JC, Calvert G, Tull F, McDonald D, Maloney WJ (2004) Reasons for revision hip surgery: a retrospective review. Clin Orthop Relat Res 429:188–192
Harris WH, Schiller AL, Scholler JM, Freiberg RA, Scott R (1976) Extensive localized bone resorption in the femur following total hip replacement. J Bone Joint Surg Am 58(5):612–618
Onodera S, Nishihira J, Iwabuchi K, Koyama Y, Yoshida K, Tanaka S, Minami A (2002) Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. J Biol Chem 277(10):7865–7874
Wagner S, Gollwitzer H, Wernicke D, Langer R, Siebenrock KA, Hofstetter W (2008) Interface membrane fibroblasts around aseptically loosened endoprostheses express MMP-13. J Orthop Res 26(2):143–152
Suzuki K, Onodera S, Matsuno T, Kaneda K, Nishihira J (1996) Identification of macrophage migration inhibitory factor in synovial membranes of loosened total joint replacement. Biochem Mol Biol Int 39(3):529–537
Sedgwick AD, Sin YM, Edwards JC, Willoughby DA (1983) Increased inflammatory reactivity in newly formed lining tissue. J Pathol 141(4):483–495
Edwall L, Carlström K, Jonasson AF (2005) Markers of collagen synthesis and degradation in urogenital tissue from women with and without stress urinary incontinence. Neurourol Urodyn 24(4):319–324
Wooley PH, Morren R, Andary J, Sud S, Yang SY, Mayton L, Markel D, Sieving A, Nasser S (2002) Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials 23:517–526
Phillips PA, McCarroll JA, Park S, Wu MJ, Pirola R, Korsten M, Wilson JS, Apte MV (2003) Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover. Gut 52(2):275–282
Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, Bucala R (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365(6448):756–759
Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R (1994) Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33(47):14144–14155
Mizue Y, Nishihira J, Miyazaki T, Fujiwara S, Chida M, Nakamura K, Kikuchi K, Mukai M (2000) Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. Int J Mol Med 5(4):397–403
Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R (1999) An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 5(3):181–191
Nishihira J, Koyama Y, Mizue Y (1998) Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine 10(3):199–205
Ogawa H, Nishihira J, Sato Y, Kondo M, Takahashi N, Oshima T, Todo S (2000) An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine 12(4):309–314
Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, Weedon H, Holdsworth SR, Bucala R, Morand EF (1999) Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 42(8):1601–1608
Morand EF, Leech M (2005) Macrophage migration inhibitory factor in rheumatoid arthritis. Front Biosci 10:12–22
Lacey D, Sampey A, Mitchell R, Bucala R, Santos L, Leech M, Morand E (2003) Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum 48(1):103–109
Schurigt U, Pfirschke C, Irmler IM, Hückel M, Gajda M, Janik T, Baumgrass R, Bernhagen J, Bräuer R (2008) Interactions of T helper cells with fibroblast-like synoviocytes: up-regulation of matrix metalloproteinases by macrophage migration inhibitory factor from both Th1 and Th2 cells. Arthritis Rheum 58(10):3030–3040
Ichiyama H, Onodera S, Nishihira J, Ishibashi T, Nakayama T, Minami A, Yasuda K, Tohyama H (2004) Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide(LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF). Cytokine 26(5):187–194
Best AJ, Fender D, Harper WM, McCaskie AW, Oliver K, Gregg PJ (1998) Current practice in primary total hip replacement: results from the National Hip Replacement Outcome Project. Ann R Coll Surg Engl 80(5):350–355
Goodman SB, Lind M, Song Y, Smith RL (1998) In vitro, in vivo, and tissue retrieval studies on particulate debris. Clin Orthop Relat Res 352:25–34
Archibeck MJ, Jacobs JJ, Roebuck KA, Glant TT (2001) The basic science of periprosthetic osteolysis. Instr Course Lect 50:185–195
Atkins RM, Langkamer VG, Perry MJ, Elson CJ, Collins CM (1997) Bone–membrane interface in aseptic loosening of total joint arthroplasties. J Arthroplasty 12(4):461–464
Goodman SB, Huie P, Song Y, Schurman D, Maloney W, Woolson S, Sibley R (1998) Cellular profile and cytokine production at prosthetic interfaces. Study of tissues retrieved from revised hip and knee replacements. J Bone Joint Surg Br 80(3):531–539
Goldring SR, Schiller AL, Roelke M, Rourke CM, O’Neill DA, Harris WH (1983) The synovial-like membrane at the bone–cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg Am 65(5):575–584
Kim KJ, Rubash HE, Wilson SC, D’Antonio JA, McClain EJ (1993) A histological and biochemical comparison of the interface tissues in cementless and cemented hip prostheses. Clin Orthop Relat Res 287:142–152
Yokohama Y, Matsumoto T, Hirakawa M, Kuroki Y, Fujimoto N, Imai K, Okada Y (1995) Production of matrix metalloproteinases at the bone–implant interface in loose total hip replacements. Lab Invest 73(6):899–911
Syggelos SA, Eleftheriou SC, Giannopoulou E, Panagiotopoulos E, Aletras AJ (2001) Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses. J Rheumatol 28(6):1319–1329
Ma GF, Ali A, Verzijl N, Hanemaaijer R, TeKoppele J, Konttinen YT, Salo J (2006) Increased collagen degradation around loosened total hip replacement implants. Arthritis Rheum 54(9):2928–2933
Gelb H, Schumacher HR, Cuckler J, Baker DG (1994) In vivo inflammatory response to polymethylmethacrylate particulate debris: effect of size, morphology, and surface area. J Orthop Res 12(1):83–92
Chambers TJ, Fuller K (1985) Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact. J Cell Sci 76:155–165
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pan, X., Mao, X., Cheng, T. et al. Macrophage migration inhibitory factor: a regulator of MMP13 and inflammation in titanium particles-stimulated air pouch in vivo. Mol Cell Biochem 357, 313–321 (2011). https://doi.org/10.1007/s11010-011-0902-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-011-0902-6